Sponsored Links
| FDA Approves Kalbitor For Treating Potentially Life-Threatening Attacks Of Hereditary Angioedema |
 |
 |
 |
| Medical News - Hematology | |||
|
The U.S. Food and Drug Administration approved Kalbitor (ecallantide) on Dec. 1 to treat sudden and potentially life-threatening fluid buildup that can occur in people with a rare genetic condition known as hereditary angioedema (HAE)... Read more: Blood / Hematology News From Medical News Today
|